ArticleBrain, behavior, & immunity - health2026
Sellar-parasellar Epstein-Barr virus associated smooth muscle tumour mimicking a pituitary adenoma: A case report.
Article in Brain, behavior, & immunity - health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus-associated smooth muscle tumours (EBV-SMTs) are rare mesenchymal neoplasms. These tumours almost exclusively occur in immunocompromised individuals, with the three main causes being Human Immunodeficiency Virus (HIV), post-organ transplantation immunosuppressants and congenital immunodeficiency. We report the case of an intracranial Epstein-Barr virus-associated smooth muscle tumour in a 54-year-old male with a long-standing history of HIV and immunosuppression. This tumour originated in the sellar region and extended into the cavernous sinus. To the authors' knowledge, this is the fourth reported case of a sellar EBV-SMT. Diagnosis is dependent on histopathological analysis and despite having an indolent course, EBV-SMTs with central nervous system invasion are likely to cause neurological deficits, which can hinder survival and quality of life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.